Intended for healthcare professionals

  1. Research
  2. Association of upper...
  3. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study
Papers

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7119.1333 (Published 22 November 1997) Cite this as: BMJ 1997;315:1333

Related articles

See more

Cited by...

  • Evaluation of a complex intervention to improve primary care prescribing: a phase IV segmented regression interrupted time series analysis
  • Nonsteroidal Antiinflammatory Drugs for Axial Spondyloarthritis: A Cochrane Review
  • Protocol for the Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) study: a cluster randomised controlled trial using ePrescribing data
  • Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases
  • Chiropractors: clarifying the issues
  • The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs
  • The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
  • Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study
  • An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
  • The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials
  • Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes
  • Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs
  • Gastroprotective effects of oral nucleotide administration
  • Reparative properties of a commercial fish protein hydrolysate preparation
  • Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials
  • Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach
  • Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis
  • CLASS clarification: reaffirms the medical importance of the analyses and results
  • Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs
  • Are selective COX 2 inhibitors superior to traditional NSAIDs?
  • Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis
  • Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen
  • Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders
  • Bovine colostrum is a health food supplement which prevents NSAID induced gut damage
  • NSAID TOXICITY -- DOES IT DECREASE WITH CONTINUED EXPOSURE?
Back to top